All investors

Wellington Partners

Munich, Germany

Venture capitalSeedSeries ASeries BGrowth
Ticket size
Not published
Activity
Last deal May 2026
Visit website

About

European venture capital firm investing in early- and growth-stage life science companies since 1998.

Headquarters
Munich, Germany
Invests in
Germany, Europe

Last checked 19 November 2026

Industries

  • Generalist
  • Health
  • Biotech
  • Industrial tech

Latest deal

May 2026

Nuclidium Series B extension closed (CHF 105m total); portfolio news 2026-11-17 Beren FDA approval

Source

Work at Wellington Partners? Claim this listing to keep it up to date.

Claim this fund

Something wrong or out of date? Tell us and we'll fix it.

Report a mistake

We list funds from public sources and check each one's website and recent activity. No guarantee of accuracy, and this is not investment advice.